Long-Term Dietary Intake and Nutritional Deficiencies following Sleeve Gastrectomy or Roux-En-Y Gastric Bypass in a Mediterranean Population.
ABSTRACT Data on long-term dietary changes and nutritional deficiencies after sleeve gastrectomy (SG) in grade 3 obese patients are scarce.
To prospectively compare dietary changes and nutritional deficiencies in grade 3 obese patients 5 years after SG and Roux-en-y gastric bypass (GBP).
Three hundred and fifty-five patients who had SG (n=61) or GBP (n=294) (May 2001-December 2006) at a Spanish university hospital.
Longitudinal, prospective, observational study. PRIMARY OUTCOMES/STATISTICAL ANALYSES: Changes in energy, macronutrient, and micronutrient intake, and weight loss were analyzed using mixed models for repeated measurements.
At the 5-year follow-up visit, the percentage of excess weight loss (P=0.420) and daily energy intake (P=0.826), as well as the proportion of energy from carbohydrates (P=0.303), protein (P=0.600), and fat (P=0.541) did not differ between surgical groups. Energy intake (P=0.004), baseline weight (P<0.001), and time period (P<0.001), but not the proportion of different macronutrients or the type of surgery, independently predicted the percentage excess weight loss over time. After SG or GBP, the mean daily dietary intake of calcium, magnesium, phosphorus, and iron was less than the current recommendations. Despite universal supplementation, the prevalence of nutritional deficiencies was comparable after SG or GBP, with 25-hydroxyvitamin D being the most commonly observed deficiency (SG, 93.3% to 100%; GBP, 90.9% to 85.7%, P=not significant). In an adjusted multivariate regression model, energy intake and lipid intake independently predicted plasma 25(OH)-vitamin D levels.
Data show that SG and GBP are associated with similar long-term weight loss with no differences in terms of dietary intake. Furthermore, data demonstrate that both types of surgeries carry comparable nutritional consequences.
- SourceAvailable from: Abdulzahra Hussain
[Show abstract] [Hide abstract]
- "Hypovitaminosis D and secondary hyperparathyroidism were associated with morbid obesity and therefore calcium deficiencies and acute hypocalcemia syndromes were reported following BS , (L2++), especially in patients who had thyroidectomy before , (L2++). 25-hydroxyvitamin D was the most commonly observed deficiency after SG & LRYGB , (L2++) while the major macronutrient deficiency after bariatric surgery was protein malnutrition , (L2++). A number of gastrointestinal or extra-gastrointestinal symptoms had raised the suspicion of malabsorption or dumping syndromes. "
ABSTRACT: The demand for bariatric surgery is increasing and the postoperative complications are seen more frequently. The aim of this paper is to review the current outcomes of bariatric surgery emergencies and to formulate a pathway of safe management. The PubMed and Google search for English literatures relevant to emergencies of bariatric surgery was made, 6358 articles were found and 90 papers were selected based on relevance, power of the study, recent papers and laparoscopic workload. The pooled data was collected from these articles that were addressing the complications and emergency treatment of bariatric patients. 830,998 patients were included in this review. Bariatric emergencies were increasingly seen in the Accident and Emergency departments, the serious outcomes were reported following complex operations like gastric bypass but also after gastric band and the causes were technical errors, suboptimal evaluation, failure of effective communication with bariatric teams who performed the initial operation, patients factors, and delay in the presentation. The mortality ranged from 0.14 %-2.2 % and increased for revisional surgery to 6.5 % (p = 0.002) .Inspite of this, mortality following bariatric surgery is still less than that of control group of obese patients (p = value 0.01). Most mortality and catastrophic outcomes following bariatric surgery are preventable. The awareness of bariatric emergencies and its effective management are the gold standards for best outcomes. An algorithm is suggested and needs further evaluation.World Journal of Emergency Surgery 12/2013; 8(1):58. DOI:10.1186/1749-7922-8-58 · 1.06 Impact Factor
[Show abstract] [Hide abstract]
- "Gastric surgery is mostly needed for the treatment of gastric cancer. After gastrectomy (GX), the daily dietary intake of calcium, magnesium, phosphorus, iron, zinc, vitamin D, vitamin B12, and folic acid is reported to be lower than the recommendations [1–3]. In particular, GX impairs calcium and vitamin D metabolism, leading to a risk of bone disease including not only osteoporosis, but also osteomalacia or a mixed pattern of osteoporosis osteomalacia with secondary hyperparathyroidism [4–7]. "
ABSTRACT: The aim of the present study was to examine the influence of gastrectomy (GX) on cortical and cancellous bones in rats. Twenty male Sprague-Dawley rats were randomized into the two groups of 10 animals each: a sham operation (control) group and a GX group. Seven weeks after surgery, the bone mineral content and density (BMC and BMD, resp.) and the mechanical strength of the femur were determined, and bone histomorphometric analyses were performed on the tibia. GX induced decreases in the BMC, BMD, ultimate force, work to failure, and stiffness of the femoral distal metaphysis and the BMC, BMD, and ultimate force of the femoral diaphysis. GX induced a decrease in cancellous bone mass, characterized by an increased osteoid thickness, osteoid surface, osteoid volume, and bone formation. GX also induced a decrease in cortical bone mass, characterized by increased endocortical bone resorption. The GX induced reductions in the bone mass and strength parameters were greater in cancellous bone than in cortical bone. The present study showed that the response of bone formation, resorption, and osteoid parameters to GX and the degree of GX-induced osteopenia and the deterioration of bone strength appeared to differ between cortical and cancellous bones in rats.Gastroenterology Research and Practice 05/2013; 2013:381616. DOI:10.1155/2013/381616 · 1.75 Impact Factor
[Show abstract] [Hide abstract]
- "2012 Yes NR Yes Yes Moize et al.  "
ABSTRACT: Background The effective treatment of postoperative anemia and nutritional deficiencies is critical for the successful management of bariatric patients. However, the evidence for nutritional risk or support of bariatric patients remains scarce. Objectives To assess current evidence of the association between 2 methods of bariatric surgery—sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB)—and postoperative anemia and nutritional deficiencies. Settings Meta analysis Methods MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched for English-language studies using a list of keywords. Reference lists from relevant review articles were also searched. In our meta-analysis, we included studies with a duration of >12 months, those comparing SG with RYGB, and those with available outcome data for postoperative anemia and iron and vitamin B12 deficiencies. Of 36 potentially relevant studies, 9 met the inclusion criteria. Data were combined by means of a fixed-effects model or random-effects model. Results Compared with the SG group, the odds ratio for postoperative vitamin B12 deficiency in the RYGB group was 3.55 (95% confidence interval, 1.26–10.01; P < 0.001). In the subgroup analysis, studies in which prophylactic iron or vitamin B12 was administered lost significance in the odds ratio for postoperative vitamin B12 deficiency. Conclusions Our findings suggest that SG is more beneficial than RYGB with regard to postoperative vitamin B12 deficiency risk, whereas the 2 methods are comparable with regard to the risk of postoperative anemia and iron deficiency. Postoperative prophylactic iron and B12 supplementation, in addition to general multivitamin and mineral supplementation, is recommended based on the comparable deficiency risk of the 2 methods, as indicated by subgroup analysis.Surgery for Obesity and Related Diseases 01/2013; 10(4). DOI:10.1016/j.soard.2013.12.005 · 4.94 Impact Factor